The Medical Daily published a comprehensive news article on the development of male contraceptives, highlighting Vasalgel’s journey to market. Journalist Stephanie Castillo interviewed Parsemus Foundation’s Director Elaine Lissner, who provided insight into why men are demanding new contraceptive options now more than ever. Lissner talked about Vasalgel’s timeline, cost and promise to revolutionize the way we think about birth control. Check out “Male Birth Control, Like Vasalgel, Is Closer To Becoming A Reality; Here’s Everything We Know So Far”.
In-depth story on Vasalgel
